LABDDirexion Daily S&P Biotech Bear 3X Shares
Chart data are delayed by 15 minutes.
Main metrics
Providers
All 1 issuers →Chains
All 2 chains →About LABD
Direxion Daily S&P Biotech Bear 3X Shares is a leveraged inverse exchange-traded fund designed to deliver daily investment results that are the opposite, at three times the magnitude, of the S&P Biotechnology Select Industry Index. The fund uses financial instruments such as swap agreements, futures contracts, and short positions to create its exposure to U.S. biotechnology companies. Its strategy is centered on short-term index tracking rather than long-term holding, making it a specialized tool for market participants seeking daily bearish exposure to the biotechnology sector. LABD is part of Direxion’s lineup of sector-focused leveraged ETFs and plays a distinct role in providing tactical access to biotechnology market movements without directly owning the underlying stocks.
| Ex-date | Amount / share | Status |
|---|---|---|
| Jun 23, 2026 | $0.075 USD | Paid |
| Mar 24, 2026 | $0.09 USD | Paid |
| Dec 23, 2025 | $0.229 USD | Paid |
| Sep 23, 2025 | $2.60 USD | Paid |
| Jun 24, 2025 | $3.70 USD | Paid |
| Mar 25, 2025 | $0.0546 USD | Paid |
| Dec 23, 2024 | $12.60 USD | Paid |
| Sep 24, 2024 | $0.0577 USD | Paid |
| Jun 25, 2024 | $0.089 USD | Paid |
| Mar 19, 2024 | $0.0664 USD | Paid |
| Dec 21, 2023 | $0.0846 USD | Paid |
| Sep 19, 2023 | $19.20 USD | Paid |
| Jun 21, 2023 | $0.0999 USD | Paid |
| Mar 21, 2023 | $0.2182 USD | Paid |
| Dec 20, 2022 | $0.0918 USD | Paid |
| Mar 24, 2020 | $0.9952 USD | Paid |
| Dec 23, 2019 | $0.278 USD | Paid |
| Sep 24, 2019 | $1.1708 USD | Paid |
| Jun 25, 2019 | $1.7478 USD | Paid |
| Mar 19, 2019 | $1.1286 USD | Paid |
| Dec 27, 2018 | $3.8268 USD | Paid |
| Sep 25, 2018 | $1.716 USD | Paid |
| Jun 19, 2018 | $0.4876 USD | Paid |
| Mar 20, 2018 | $0.888 USD | Paid |
| Date | Type | Details |
|---|---|---|
| Sep 29, 2025 | Reverse split | 1-for-1010 shares → 1 share |
| Aug 28, 2020 | Reverse split | 1-for-2020 shares → 1 share |
| Mar 29, 2018 | Reverse split | 1-for-1010 shares → 1 share |
Splits, mergers and other corporate actions appear here. How each issuer reflects them on-chain varies by product.





